AQR Capital Management’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$62.1M Sell
1,736,275
-871,815
-33% -$31.2M 0.05% 482
2025
Q1
$80.4M Buy
2,608,090
+704,414
+37% +$21.7M 0.08% 330
2024
Q4
$48.6M Buy
1,903,676
+1,240,384
+187% +$31.6M 0.06% 390
2024
Q3
$18.7M Sell
663,292
-122,275
-16% -$3.45M 0.03% 647
2024
Q2
$20.7M Buy
785,567
+320,606
+69% +$8.45M 0.03% 567
2024
Q1
$14.1M Buy
464,961
+34,000
+8% +$1.03M 0.02% 608
2023
Q4
$12.1M Sell
430,961
-204,722
-32% -$5.73M 0.02% 633
2023
Q3
$17M Buy
635,683
+448,127
+239% +$12M 0.04% 518
2023
Q2
$5.7M Buy
+187,556
New +$5.7M 0.01% 853